ZEPOSIA

bristol-myers squibb canada🇨🇦 Health Canada

Approval Id: 8402270d6d4ec064
Drug Approval Canada Name: ZEPOSIA
Product Name: ZEPOSIA
Status: Marketed
Status Date: 2025-02-14
Original Market Date: 2020-11-12
Din: 02506009
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:04.16
Atc Original: L04AE02 OZANIMOD
Atc Name: l 04 ae 02
Aig Number: 0262519001
Company Name: bristol-myers squibb canada
Company Address: 2344 Boul. Alfred-Nobel, Suite 300, St-Laurent, Quebec, Canada, H4S 0A4

OZANIMOD (OZANIMOD HYDROCHLORIDE)

0.23 MG

OZANIMOD (OZANIMOD HYDROCHLORIDE)

0.46 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8402270d6d4ec064

Type

Standard